Abstract: An induction machine with integrated magnetic gears is disclosed. The machine comprises two rotors and two stators. An outer stator has ferromagnetic material, producing a rotating magnetic field with a defined number of pole pairs synchronized with a supply frequency. A high speed rotor has ferromagnetic material and a combination of rotor bars and permanent magnet pole pieces selected so that the permanent magnet pole pieces do not interact with the outer stator magnetic field. The high speed rotor rotation is asynchronously coupled to the outer stator magnetic field. An inner stator has ferromagnetic steel segments that modulate the field produced by the high speed rotor permanent magnets. A low speed inner rotor has ferromagnetic material and permanent magnet pole pieces, the low speed inner rotor counter-rotating to the high speed rotor. The low speed inner rotor is synchronously coupled to the high speed rotor using modulation harmonics.

Abstract: A method of conducting a well treatment service job. The method comprises assembling an oilfield communication network. The oilfield communication network comprises a plurality of mobile terminals distributed across a plurality of well sites and a plurality of base transceiver stations. Some of the mobile terminals are coupled to each other in wireless communication by the base transceiver stations. The method further comprises preparing a well for the well treatment service job, performing one or more well treatment steps, collecting one or more data parameters associated with the well treatment service job, and communicating the one or more data parameters from at least a first one of the mobile terminals via the oilfield communication network.

Abstract: Hexaamminecobalt(III) chloride, also called Cohex, reduces the extent of viral infection, including difficult to treat infections caused by Ebola virus and HIV. Disclosed are methods for treating a viral infection, comprising administering to a patient a cobalt(III) hexammine compound in an amount effective to reduce an extent of a viral infection. Also disclosed are kits for delivery of a cobalt(III) hexammine compound by injection.

Abstract: Disclosed herein is a method of: administering to a subject suspected of being infected with a bacterium, a composition of a cobalt (III) compound having the formula CoR1R2R3R4R5R6 or a salt thereof and an antibiotic compound. Each of R1, R2, R3, R4, and R5 is the same or different and includes an N-based ligand donor atom selected from the group consisting of ammonia, primary amine, or secondary amine, or salt thereof. R6 is a ligand. Also disclosed herein is a composition of the above cobalt (III) compound and an antibiotic compound.

Abstract: A method of conducting a well treatment service job, comprising assembling an oilfield communication network comprising a plurality of mobile terminals distributed across a plurality of well sites and a plurality of base transceiver stations, wherein some of the mobile terminals are coupled to each other in wireless communication by the base transceiver stations; preparing a well for the well treatment service job; performing one or more well treatment steps; collecting one or more data parameters associated with the well treatment service job; and communicating the one or more data parameters from at least a first one of the mobile terminals via the oilfield communication network.

Abstract: A method of making a macrocyclic chelator comprising converting Co(II)Cl2 to a stabilized Co(III) complex, reacting the Co(III) complex with a cyclen ligand comprising a carboxylic acid or a methyl benzoic acid moiety through which amine bond formation with a primary amine can be achieved and reacting the Co(III) cyclen carboxylic acid or methyl benzoic acid complex with a suitable modified oligonucleotide to form a sequence-specific gene silencing moiety. A method comprising coordinating a kinetically inert ion to a macrocyclic chelator or ligand, bonding a first functional group, reacting with an oligonucleotide, bonding a second functional group, attaching the first functional group to the second functional group, binding the macrocyclic chelator to a target thus inhibiting translation, wherein the macrocyclic chelator hydrolyzes a photodiester bond.

Abstract: The present invention is generally directed to a method of prophylaxis against viral infection of a cell or subject or a method of treating a subject infected with a virus including administering an antiviral composition having the general Structure III, wherein each of R1, R2, R3, R4, R5 and R6 is the same or different and includes an N-based ligand donor atom selected from the group consisting of ammonia, primary amine or secondary amine, or salt thereof. The present invention is also generally directed to a method of preparing an antiviral agent including providing a cobalt pentammine salt having a non-amine coordination site and mono-substituting the non-amine coordination site with a functional group incorporating a strong coordinator atom to cobalt to form a CoHex structure of Structure III, in which R1 incorporates the functional group having the strong coordinator atom coordinated with the cobalt atom, or a salt thereof.

Abstract: A composition comprising a kinetically inert ion coordinated to a macrocyclic chelator or ligand, a first functional group bonded to the macrocyclic chelator or ligand, an oligonucleotide, and a second functional group bonded to the oligonucleotide, wherein the first functional group covalently bonds to the second functional group.